Spots Global Cancer Trial Database for 80mg regorafenib at week 1
Every month we try and update this database with for 80mg regorafenib at week 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer | NCT05730673 | CCR5 Microsatellite ... Metastatic Colorectal Canc... | 700mg leronlima... 80mg Regorafeni... 120mg Regorafen... 160 mg Regorafe... | 18 Years - | CytoDyn, Inc. |